Back

Verrica Pharmaceuticals to present YCANTH and VP-315 data

Verifying
  • Verrica Pharmaceuticals plans to present YCANTH and VP-315 data.
  • Two upcoming dermatology conferences are scheduled to feature the presentations.
  • The announcement does not identify the conferences or disclose the data findings.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.